Tag: breast cancer

New Data Strengthen Case for Prechemotherapy Statins

Evidence supporting the use of statins to protect against cardiotoxic chemotherapy has been strengthened with new data from a propensity-matched analysis. Among women with breast...

Even for Wealthy, US Healthcare Can’t Match Care in Other Nations

(Reuters Health) – When it comes to health care, even privileged white Americans fare worse than the average citizens of 12 other developed countries, a...

Doctors Underreport Side Effects of Breast Irradiation

There is a substantial mismatch between patient and physician reports of toxicity during radiotherapy for breast cancer, according to an analysis of nearly 10,000 U.S....

Long-term APBI Cosmetic, Toxicity Data Reported

Long-term cosmetic and toxicity outcomes are good for both accelerated partial breast irradiation (APBI) delivered with 3D-conformal radiotherapy and whole-breast irradiation (WBI), with the latter...

Democrats Are Running Hard on Health Care in Georgia’s Runoffs

In this Nov. 20, 2020, photo, Vice President Mike Pence and Kelly Loeffler wave to the crowd during a Defend the Majority Rally in Canton,...

Most Common Cancer Diagnosis Globally: Breast Surpasses Lung

Breast cancer now tops the list of the most commonly diagnosed cancers worldwide, surpassing lung cancer for the first time, according to the latest global...

What to Know About 3D Mammograms

Since your last mammogram, your doctor might have replaced conventional 2D images with 3D technology called breast tomosynthesis, or 3D mammogram. Though the new technology...

Pregnancy After Breast Cancer Doesn’t Increase Recurrence Risk

Breast cancer survivors are less likely to get pregnant and have higher risks of some delivery and fetal complications, according to a meta-analysis reported at the 2020...

Adding Atezolizumab to Chemo Doesn’t Worsen QOL in Early TNBC

Adding the immune checkpoint inhibitor atezolizumab to first-line therapy for early triple-negative breast cancer (TNBC) did not significantly worsen patients’ quality of life, according to...

First-in-Class ADC Has Benefit Across mTNBC Subgroups

The antibody–drug conjugate sacituzumab govitecan (SG) (Trodelvy) appears to be effective across biomarker subgroups for women with metastatic triple-negative breast cancer (mTNBC) that has progressed...

Even More Women May Forgo Chemo for Breast Cancer

More women with early-stage breast cancer may safely forgo chemotherapy, suggests an interim analysis that had a median follow-up of 5 years of the large-scale...

Charting of the Human Genome, 20 Years Later

Twenty years ago, President Bill Clinton announced completion of what was arguably one of the greatest advances of the modern era: the first draft sequence...

Breast Cancer Facts Doctors Might Not Tell You

Florida real estate agent Sondra Burwick learned in 1996 that she had ductal carcinoma in situ (DCIS) in her right breast. DCIS, also called stage...

Palbociclib Disappoints in HR+, HER2– Breast Cancer

The CDK4/6 inhibitor palbociclib provides no significant benefit in patients with hormone receptor–positive (HR+), HER2-negative primary breast cancer, according to first results from the PENELOPE-B...

Beta-Blocker May Improve Melanoma Treatment Response

Response rates were high without dose-limiting toxicities in a small phase 1 study that evaluated the addition of propranolol to pembrolizumab in treatment-naive patients with...

Obesity Drives Breast Cancer Risk for Black Women

By Robert Preidt HealthDay Reporter MONDAY, Dec. 7, 2020 (HealthDay News) — Obesity may be a major reason Black American women with early breast...

What’s Hot, Including a Major Chemotherapy Trial

The “hottest” presentation at the upcoming 2020 San Antonio Breast Cancer Symposium (SABCS) comes from RxPONDER (abstract GS3-00), a major randomized clinical trial assessing use...

Immediate Breast Reconstruction Feasible Following Neoadjuvant Chemo

NEW YORK (Reuters Health) – Long-term oncologic outcomes following neoadjuvant chemotherapy for breast cancer are similar with immediate breast reconstruction and conventional mastectomy alone, regardless...

New Assay Platform Enhances Detection of Circulating Breast Cancer Cells

NEW YORK (Reuters Health) – Detection of circulating tumor cells (CTCs) in a breast cancer model was improved by a novel assay platform that uses...

Vision Impairment Tied to Less Use of Cancer Screenings by Older Adults

(Reuters Health) – Older adults with vision impairment are less likely to receive recommended breast and colon cancer screenings than peers without vision problems, a...

‘Glass Ceiling Shattered’ by Female Breast Surgeons. How?

In the United States, the field of surgery is dominated by men, but women have broken through in one subspecialty ― breast surgery. During the...

A Guide to the New Agents Reshaping Ovarian Cancer Treatment

The treatment of ovarian cancer has evolved considerably in the last few years, with the approval of several PARP inhibitors, antiangiogenic agents, and other therapies...

New Thermography Shows Efficacy for Breast Cancer Screening

Sensitivity and area under the curve (AUC) analyses of thermography that is combined with diagnostic software demonstrate “the efficacy of the tool for breast cancer...

pCR in HER2+ Breast Cancer Predicts Long-Term Survival

A pathologic complete response (pCR) to targeted therapy in HER2-positive breast cancer portends good long-term outcomes, according to final results of the phase 3 NeoALTTO/BIG...

Image-Guided Biopsy May Help Some Avoid Breast Cancer Surgery

NEW YORK (Reuters Health) – Following neoadjuvant chemotherapy, image-guided vacuum-assisted biopsy (VAB) can reliably identify a subgroup of patients with no residual disease in the...